Class II · ModerateActive recall
Vasopressin In 0.9% Sodium Chloride
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028.
Where it was soldUS Nationwide; Puerto Rico; and Chile.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
CGMP Deviations
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byBaxter Healthcare Corporation
| Brand name | VASOPRESSIN IN 0.9% SODIUM CHLORIDE |
| Generic name | VASOPRESSIN IN 0.9% SODIUM CHLORIDE |
| Active ingredient(s) | VASOPRESSIN |
| Distributed by / for | Baxter Healthcare Corporation |
| NDC | 0338-9647-12 |
Show the full FDA record
| Full product label | Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12. |
| Recalling firm | Baxter Healthcare Corporation |
| Distribution | US Nationwide; Puerto Rico; and Chile. |
| Quantity | N/A |
| Recall initiated | 2026-08-06 |
| Report date | 2026-09-09 |
| Recall completed | — |
| Recall number | D-0819-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Deerfield IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.